Project Grant K01DK147658
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Illinois $295,494 on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct the ACCELERATED-T2D study through August 31, 2030. This project grant funds research examining the pathways through which socioeconomic status (SES) influences glycemic control and diabetes complications in patients with Type 2...
- Summary of Federal Project Grant Award The University of Michigan received a $769,155 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), with an award date of September 12, 2025, and completion date of July 31, 2030. The grant funds the Michigan Diabetes Project, a research initiative designed to develop and evaluate a virtually administered,...
- Federal Project Grant Award Summary Rush University Medical Center received a $942,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 16, 2025, with a completion date of August 31, 2028. The award funds a feasibility research project designed to develop and evaluate a primary care-based weight management intervention program for patients...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Johns Hopkins University a $232,875 Project Grant on September 5, 2025, to conduct a mixed-methods study evaluating clinician communication practices around glycemic management for patients with diabetes. Under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), the research will characterize communication quality in primary care visits,...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the Regents of the University of Michigan a $779,978 Project Grant on September 6, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative addresses critical health disparities in diabetes management by developing and testing adaptive intervention sequences designed to improve outcomes for individuals with...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded a $784,276 Project Grant to the University of Houston System on July 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports the "Supporting Monitoring and Remote Tracking for Prediabetes (SMART Prediabetes)" initiative, a five-year research project extending through June 30, 2031. The project delivers a...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of California, Davis a Project Grant of $151,448 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on May 15, 2026, with completion targeted for January 31, 2031. This award funds research to improve healthcare transitions from pediatric to adult care for adolescents and young adults (AYAs) with Type 1 Diabetes (T1D)....
- Federal Project Grant Award Summary The University of Chicago received a $172,904 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026, through March 31, 2031. This K23 career development award funds research to develop and validate clinically actionable tools for individualizing glucagon-like peptide-1 receptor agonist (GLP-1RA)...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $237,750 Project Grant to the Trustees of Indiana University (Indiana University Indianapolis) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period September 15, 2025 through August 31, 2027. The award supports a rigorous qualitative research study examining nephrology practices' participation decisions and care model reforms...
- Federal Project Grant Award Summary Colorado State University's Sponsored Programs division received a $119,536 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 6, 2026, with completion targeted for April 30, 2028. This R03 award supports implementation science research that enhances evaluation of "What Can I Eat?" Healthy...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $160,575 to the University of Illinois (awarded July 1, 2026, with completion by March 31, 2029) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct dissemination and implementation research examining how Federally Qualified Health Centers (FQHCs) adopt Medicaid Alternative Payment Models (APMs) and evidence-based practices in diabetes care. FQHCs serve over 30 million patients annually, including approximately 10 percent of all individuals with diabetes in the United States, predominantly in rural and low-income communities and health professional shortage areas. The research directly addresses NIDDK's strategic priorities by investigating the real-world implementation mechanisms of APMs and evidence-based diabetes care practices across diverse clinic settings. The project delivers three primary research products: (1) qualitative analysis identifying APM and FQHC characteristics influencing implementation success and evidence-based practice adoption through structured interviews; (2) quantitative assessment of associations between APM/FQHC features and implementation outcomes via national survey methodology; and (3) impact evaluation of APM types on hemoglobin A1C (HbA1C) control rates utilizing Uniform Data System data and difference-in-differences statistical design. Guided by the Consolidated Framework for Implementation Research and Proctor's Implementation Outcomes Framework, the study generates actionable evidence and insights intended for policymakers and FQHC leadership to optimize chronic disease management and health outcomes in underserved populations.Federal Project Grant Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $160.6k | 6/26/26 |